Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
131.95
+3.95 (3.09%)
At close: Aug 1, 2025, 4:00 PM
132.45
+0.50 (0.38%)
After-hours: Aug 1, 2025, 7:58 PM EDT
Hess Corporation Market Cap
Biogen has a market cap or net worth of $19.35 billion as of August 1, 2025. Its market cap has decreased by -41.81% in one year.
Market Cap
19.35B
Enterprise Value
23.18B
1-Year Change
-41.81%
Ranking
Category
Stock Price
$131.95
Market Cap Chart
Since December 1, 1998, Biogen's market cap has increased from $617.50M to $19.35B, an increase of 3,032.92%. That is a compound annual growth rate of 13.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 19.35B | -13.18% |
Dec 31, 2024 | 22.28B | -40.57% |
Dec 29, 2023 | 37.50B | -5.97% |
Dec 30, 2022 | 39.88B | 13.15% |
Dec 31, 2021 | 35.24B | -6.47% |
Dec 31, 2020 | 37.68B | -29.63% |
Dec 31, 2019 | 53.54B | -11.69% |
Dec 31, 2018 | 60.63B | -10.00% |
Dec 29, 2017 | 67.37B | 9.19% |
Dec 30, 2016 | 61.70B | -9.65% |
Dec 31, 2015 | 68.29B | -14.82% |
Dec 31, 2014 | 80.16B | 21.39% |
Dec 31, 2013 | 66.04B | 90.69% |
Dec 31, 2012 | 34.63B | 29.54% |
Dec 30, 2011 | 26.73B | 67.31% |
Dec 31, 2010 | 15.98B | 3.27% |
Dec 31, 2009 | 15.47B | 11.34% |
Dec 31, 2008 | 13.90B | -16.78% |
Dec 31, 2007 | 16.70B | 0.70% |
Dec 29, 2006 | 16.58B | 7.90% |
Dec 30, 2005 | 15.37B | -30.83% |
Dec 31, 2004 | 22.22B | 288.89% |
Dec 31, 2003 | 5.71B | 12.55% |
Dec 31, 2002 | 5.08B | -51.71% |
Dec 31, 2001 | 10.51B | 21.91% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 684.37B |
Johnson & Johnson | 402.94B |
AbbVie | 344.84B |
AstraZeneca | 232.21B |
Novartis AG | 224.47B |
Abbott Laboratories | 221.54B |
UnitedHealth Group | 215.69B |
Novo Nordisk | 211.90B |